Lund, Sweden

Chin Shing Ho

This inventor holds 4 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignee: Hamlet Pharma Ab. Active years: 2015-2025.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Biography of Inventor Chin Shing Ho

Introduction: Chin Shing Ho is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biologically active complexes, with a focus on methods that enhance therapeutic applications.

Latest Patents: Chin Shing Ho holds four patents, with his latest inventions including a method for preparing biologically active complexes. This method involves dissolving a mixture of polypeptide elements and oleic acid in an aqueous solvent, allowing for a simple and efficient preparation process without extensive heating. Another significant patent focuses on a biologically active complex for prophylactic and nutraceutical therapy, particularly in the prevention of cancers, especially in the gastrointestinal tract.

Career Highlights: Throughout his career, Chin Shing Ho has demonstrated a commitment to advancing medical science through innovative solutions. His work has led to the development of methods that are not only effective but also practical for therapeutic use.

Collaborations: Chin Shing Ho has collaborated with esteemed colleagues, including Catharina Svanborg and Manoj Puthia. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion: Chin Shing Ho's contributions to the field of biologically active complexes highlight his role as a leading inventor. His innovative methods and collaborative efforts continue to pave the way for advancements in cancer prevention and nutraceutical therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…